Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks - Scorecard - MDSpire

Mapping ADHD Heterogeneity and Biotypes by Topological Deviations in Morphometric Similarity Networks

  • By

  • Nanfang Pan

  • Yajing Long

  • Kun Qin

  • Isaac Z. Pope

  • Qiuxing Chen

  • Ziyu Zhu

  • Ying Cao

  • Lei Li

  • Manpreet K. Singh

  • Robert K. McNamara

  • Melissa P. DelBello

  • Ying Chen

  • Alex Fornito

  • Qiyong Gong

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Characterizing ADHD Variability and Subtypes Through Topological Differences in Morphometric Similarity Networks

At a Glance

CategoryDetail
ConditionAttention-deficit/hyperactivity disorder (ADHD)
Key MechanismsNeurobiological heterogeneity characterized by morphometric similarity networks (MSNs) and hub organization of brain regions.
Target PopulationChildren aged 6 to 18 years diagnosed with ADHD.
Care SettingMultisite clinical research settings.

Key Highlights

  • ADHD presents considerable clinical heterogeneity beyond DSM-5 classifications.
  • Data-driven clustering may identify distinct neurobiological biotypes.
  • Morphometric similarity networks provide a framework for understanding brain alterations in ADHD.

Guideline-Based Recommendations

Diagnosis

  • Utilize normative modeling and morphometric similarity networks to assess ADHD.

Management

  • Consider individualized treatment approaches based on identified neurobiological profiles.

Monitoring & Follow-up

  • Regularly assess brain morphology and behavioral symptoms to track ADHD progression.

Risks

  • Failure to recognize neurobiological diversity may lead to inadequate treatment strategies.

Patient & Prescribing Data

Children with ADHD aged 6 to 18 years, excluding left-handed individuals.

Neuroimaging-derived biomarkers may inform personalized treatment plans.

Clinical Best Practices

  • Incorporate neuroimaging metrics in ADHD assessments.
  • Use data-driven approaches for subtype identification to enhance clinical decision-making.

References

Original Source(s)

Related Content